Physician profile
Neil Beri
NPI 1457763088
$51,890.41
in general payments reported to CMS, 2019-2025
27 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,271 · 2020: $32K · 2021: $13K · 2022: $4,300 · 2023: $235 · 2024: $184 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21,641.90 | 2020-2022 | |
| Medtronic, INC. | $10,911.07 | 2021-2022 | |
| Medtronic Vascular, INC. | $10,000.00 | 2020 | |
| Biotronik INC. | $3,321.74 | 2019-2025 | Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $2,318.11 | 2019-2024 | Synergy, Lux-Dx Insertable Cardiac Monitor, Opticross |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $597.61 | 2019-2021 | |
| Biosense Webster, INC. | $558.49 | 2021-2025 | Carto 3 |
| Shockwave Medical, INC | $310.31 | 2020-2022 | |
| Chiesi USA, INC. | $251.92 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $218.43 | 2019-2020 | |
| Heartflow, INC. | $197.74 | 2020-2021 | |
| Pfizer INC. | $185.63 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $183.14 | 2019-2021 | |
| Philips North America LLC | $159.59 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $143.26 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.34 | 2021 | |
| Impulse Dynamics (USA) INC. | $112.46 | 2022 | |
| Abiomed | $105.13 | 2020-2021 | |
| Medical Device Business Services, INC. | $99.00 | 2020 | |
| Acutus Medical, INC. | $91.88 | 2022 | |
| Amgen INC. | $88.23 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $67.47 | 2019-2020 | |
| Stereotaxis INC | $50.71 | 2021 | |
| Cardiva Medical, INC. | $48.47 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Kestra Medical Technology Services, INC. | $34.78 | 2025 | Assure Wcd |
| Cathworks, INC. | $34.52 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $34.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Beri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.